NEW YORK (GenomeWeb News) – Synthetic biology technology firm Triton Algae today announced it raised $5 million in a Series A equity financing round.
The investment made by Heliae Technology Holdings will go toward ongoing R&D at San Diego-based Triton, expansion of its PhycoLogix platform, and commercialization of its first product called PhycoShield.